Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 11/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 11/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 11/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 9/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 1.00 |
| ▸ | MAPT | P10636 | 8/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 1.00 |
| ▸ | HPGD | P15428 | 7/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 6/20 | 1.00 |
| ▸ | TP53 | P04637 | 6/20 | 1.00 |
| ▸ | CASP1 | P29466 | 5/20 | 1.00 |
| ▸ | CASP7 | P55210 | 5/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 5/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 3/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 6/20 | 0.82 |
| ▸ | LMNA | P02545 | 4/20 | 0.78 |
| ▸ | CDK5 | Q00535 | 3/20 | 0.78 |
| ▸ | CDK5R1 | Q15078 | 3/20 | 0.78 |
| ▸ | FTO | Q9C0B1 | 3/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Resokaempferol SCHEMBL30873045 | 1.00 | MEN1 (1.00) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| SCHEMBL24474226 | 0.91 | MEN1 (0.83) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| SCHEMBL24474345 | 0.91 | MEN1 (0.83) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| SCHEMBL24474091 | 0.91 | MEN1 (0.83) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| SCHEMBL13248718 | 0.91 | MEN1 (0.83) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| 3,7-Dihydroxyflavone SCHEMBL2396684 | 0.90 | CYP3A4 (1.00) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| 3,7-Dihydroxyflavone SCHEMBL29625323 | 0.90 | CYP3A4 (1.00) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| Fisetin SCHEMBL116861 | 0.88 | MEN1 (1.00) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| Fisetin SCHEMBL29381611 | 0.88 | MEN1 (1.00) | MEN1KMT2ACYP3A4HSD17B10KDM4E | |
| Fisetin SCHEMBL29349742 | 0.88 | MEN1 (1.00) | MEN1KMT2ACYP3A4HSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230119060-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING, AS ACTIVE INGREDIENT, COMPLEX OF BIGUANIDE-BASED COMPOUND AND FLAVONE, HYDROXYFLAVONE, FLAVANONE, FLAVONE DERIVATIVE, HYDROXYFLAVONE DERIVATIVE, OR FLAVANONE DERIVATIVE | MEDIENCE CO., LTD. (KR) | 2023-04-20 | — | — | US | claimed |
| WO-2016071505-A1 | MICROBIAL PRODUCTION OF THE FLAVONOIDS GARBANZOL, RESOKAEMPFEROL AND FISETIN | DANMARKS TEKNISKE UNIVERSITET (DK) | 2016-05-12 | — | — | WO | claimed |
| US-9155792-B2 | RecA inhibitors with antibiotic activity, compositions and methods of use | TRUSTEES OF BOSTON UNIVERSITY (US) | 2015-10-13 | — | — | US | claimed |
| US-7897637-B2 | Methods of using flavonoids to enhance memory | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2011-03-01 | — | — | US | claimed |
| US-20100029597-A1 | RECA INHIBITORS WITH ANTIBIOTIC ACTIVITY, COMPOSITIONS AND METHODS OF USE | TRUSTEES OF BOSTON UNIVERSITY (US) | 2010-02-04 | — | — | US | claimed |
| US-20090264342-A1 | COMPOSITIONS AND METHODS FOR ANTIBIOTIC POTENTIATION AND DRUG DISCOVERY | TRUSTEES OF BOSTON UNIVERSITY (US) | 2009-10-22 | — | — | US | claimed |
| EP-2028936-A2 | COMPOSITIONS AND METHODS FOR ANTIBIOTIC POTENTIATION AND DRUG DISCOVERS | TRUSTEES OF BOSTON UNIVERSITY (US) | 2009-03-04 | — | — | EP | claimed |
| WO-2008011538-A2 | METHODS OF USING FLAVONOIDS TO ENHANCE MEMORY | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) | 2008-01-24 | — | — | WO | claimed |
| US-20080021096-A1 | METHODS OF USING FLAVONOIDS TO ENHANCE MEMORY | THE SALK INSTITUTE FOR BIOLOGICAL STUDIES | 2008-01-24 | — | — | US | claimed |
| WO-2007097940-A2 | RECA INHIBITORS WITH ANTIBIOTIC ACTIVITY, COMPOSITIONS AND METHODS OF USE | TRUSTEES OF BOSTON UNIVERSITY (US) | 2007-08-30 | — | — | WO | claimed |
| WO-2007095187-A2 | COMPOSITIONS AND METHODS FOR ANTIBIOTIC POTENTIATION AND DRUG DISCOVERY | TRUSTEES OF BOSTON UNIVERSITY (US) | 2007-08-23 | — | — | WO | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| JP-2003504327-A | — | — | 2003-02-04 | — | — | JP | claimed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | claimed |
| WO-2001080855-A1 | TELOMERASE INHIBITORS AND METHODS OF THEIR USE | GERON CORPORATION (US) | 2001-11-01 | — | — | WO | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | THE TRUSTEES OF PRINCETON UNIVERSITY (US) | 2025-12-30 | — | — | US | disclosed |
| US-20250263774-A1 | DISCOVERING NEW XENOBIOTIC SUBSTRATES OF AN UDP-GLYCOSYLTRANSFERASE WITH A HIGH-THROUGHPUT METHOD | UNIV NORTH TEXAS (US) | 2025-08-21 | — | — | US | disclosed |
| WO-2001080855-A1 | TELOMERASE INHIBITORS AND METHODS OF THEIR USE | GERON CORPORATION (US) | 2001-11-01 | — | — | WO | disclosed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12507703-B2 | Methods, devices and compositions for preserving human milk | LPL, CEL, LPO | MEN1 4581/4885KMT2A 3264/4885CYP3A4 1678/4885 |
| US-20080021096-A1 | METHODS OF USING FLAVONOIDS TO ENHANCE MEMORY | FOS, CREBBP, CREB1 | MEN1 3520/4885KMT2A 1152/4885CYP3A4 4468/4885 |
| US-20090264342-A1 | COMPOSITIONS AND METHODS FOR ANTIBIOTIC POTENTIATION AND DRUG DISCOVERY | ATF1, ATF4, STING1 | MEN1 4138/4885KMT2A 3617/4885CYP3A4 3260/4885 |
| US-20100029597-A1 | RECA INHIBITORS WITH ANTIBIOTIC ACTIVITY, COMPOSITIONS AND METHODS OF USE | XPA, WRN, BLM | MEN1 2080/4885KMT2A 3866/4885CYP3A4 3512/4885 |
| US-20230119060-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING, AS ACTIVE INGREDIENT, COMPLEX OF BIGUANIDE-BASED COMPOUND AND FLAVONE, HYDROXYFLAVONE, FLAVANONE, FLAVONE DERIVATIVE, HYDROXYFLAVONE DERIVATIVE, OR FLAVANONE DERIVATIVE | SLC5A2, SLC5A1, SLC5A6 | MEN1 617/4885KMT2A 1807/4885CYP3A4 700/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.